Cargando…

Severe acute hepatitis of unknown etiology in a large cohort of children

BACKGROUND: We evaluated the proportion, clinical features, and outcomes of previously healthy children presenting to a large Canadian quaternary pediatric center with severe acute hepatitis of unknown etiology. METHODS: All patients with serum alanine aminotransferase (ALT) > 500 U/L or aspartat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Sagar, John, Tomisin, Feld, Jordan J., Shah, Hemant, Mullaithilaga, Nisa, Campigotto, Aaron, Leung, Karen, Kamath, Binita M., Ling, Simon C., Science, Michelle, Ng, Vicky L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531196/
https://www.ncbi.nlm.nih.gov/pubmed/37756118
http://dx.doi.org/10.1097/HC9.0000000000000272
_version_ 1785111662303379456
author Mehta, Sagar
John, Tomisin
Feld, Jordan J.
Shah, Hemant
Mullaithilaga, Nisa
Campigotto, Aaron
Leung, Karen
Kamath, Binita M.
Ling, Simon C.
Science, Michelle
Ng, Vicky L.
author_facet Mehta, Sagar
John, Tomisin
Feld, Jordan J.
Shah, Hemant
Mullaithilaga, Nisa
Campigotto, Aaron
Leung, Karen
Kamath, Binita M.
Ling, Simon C.
Science, Michelle
Ng, Vicky L.
author_sort Mehta, Sagar
collection PubMed
description BACKGROUND: We evaluated the proportion, clinical features, and outcomes of previously healthy children presenting to a large Canadian quaternary pediatric center with severe acute hepatitis of unknown etiology. METHODS: All patients with serum alanine aminotransferase (ALT) > 500 U/L or aspartate aminotransferase (AST) > 500 U/L between June 1, 2018, and May 31, 2022, at The Hospital for Sick Children, were identified. Subjects with only AST > 500 U/L were excluded. Clinical characteristics, investigations, and outcomes for patients without clear etiology for ALT > 500 U/L (severe acute hepatitis of unknown etiology) for our study period and from October 1 to May 31 of each year 2018–2021 were reviewed. RESULTS: Of 977 patients with ALT/AST> 500 U/L, 720 had only ALT > 500 U/L. We excluded age below 6 months (n = 99) or above 16 years (n = 66), known pre-existing liver conditions (n = 66), and ALT > 500 U/L in already admitted patients (n = 151). Among the remaining 338 children with ALT > 500 U/L at presentation, an etiology was identified in 303 subjects. 33 (9.8%) children [median age 6.1 y (range 0.5–15.5); 61% male] were confirmed as severe acute hepatitis of unknown etiology. Twenty patients (60.6%) were tested for blood adenovirus by PCR, and 1 (5%) was positive (serotype B7). Liver tissue specimens from 18 patients revealed no evidence of viral inclusions or adenovirus. Twelve (36.3%) presented with pediatric acute liver failure, with 8 (24.2%) requiring liver transplantation. There were no deaths. Hepatitis-associated aplastic anemia occurred in 5 (15%) patients. CONCLUSIONS: Of children presenting with severe acute hepatitis to a quaternary children’s hospital over a 48-month period, 9.8% had unknown etiology with no change over time. Liver transplantation remains an important treatment strategy for those presenting with pediatric acute liver failure phenotype. The frequency of cases associated with human adenovirus infection was noncontributory.
format Online
Article
Text
id pubmed-10531196
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105311962023-09-28 Severe acute hepatitis of unknown etiology in a large cohort of children Mehta, Sagar John, Tomisin Feld, Jordan J. Shah, Hemant Mullaithilaga, Nisa Campigotto, Aaron Leung, Karen Kamath, Binita M. Ling, Simon C. Science, Michelle Ng, Vicky L. Hepatol Commun Original Article BACKGROUND: We evaluated the proportion, clinical features, and outcomes of previously healthy children presenting to a large Canadian quaternary pediatric center with severe acute hepatitis of unknown etiology. METHODS: All patients with serum alanine aminotransferase (ALT) > 500 U/L or aspartate aminotransferase (AST) > 500 U/L between June 1, 2018, and May 31, 2022, at The Hospital for Sick Children, were identified. Subjects with only AST > 500 U/L were excluded. Clinical characteristics, investigations, and outcomes for patients without clear etiology for ALT > 500 U/L (severe acute hepatitis of unknown etiology) for our study period and from October 1 to May 31 of each year 2018–2021 were reviewed. RESULTS: Of 977 patients with ALT/AST> 500 U/L, 720 had only ALT > 500 U/L. We excluded age below 6 months (n = 99) or above 16 years (n = 66), known pre-existing liver conditions (n = 66), and ALT > 500 U/L in already admitted patients (n = 151). Among the remaining 338 children with ALT > 500 U/L at presentation, an etiology was identified in 303 subjects. 33 (9.8%) children [median age 6.1 y (range 0.5–15.5); 61% male] were confirmed as severe acute hepatitis of unknown etiology. Twenty patients (60.6%) were tested for blood adenovirus by PCR, and 1 (5%) was positive (serotype B7). Liver tissue specimens from 18 patients revealed no evidence of viral inclusions or adenovirus. Twelve (36.3%) presented with pediatric acute liver failure, with 8 (24.2%) requiring liver transplantation. There were no deaths. Hepatitis-associated aplastic anemia occurred in 5 (15%) patients. CONCLUSIONS: Of children presenting with severe acute hepatitis to a quaternary children’s hospital over a 48-month period, 9.8% had unknown etiology with no change over time. Liver transplantation remains an important treatment strategy for those presenting with pediatric acute liver failure phenotype. The frequency of cases associated with human adenovirus infection was noncontributory. Lippincott Williams & Wilkins 2023-09-27 /pmc/articles/PMC10531196/ /pubmed/37756118 http://dx.doi.org/10.1097/HC9.0000000000000272 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Mehta, Sagar
John, Tomisin
Feld, Jordan J.
Shah, Hemant
Mullaithilaga, Nisa
Campigotto, Aaron
Leung, Karen
Kamath, Binita M.
Ling, Simon C.
Science, Michelle
Ng, Vicky L.
Severe acute hepatitis of unknown etiology in a large cohort of children
title Severe acute hepatitis of unknown etiology in a large cohort of children
title_full Severe acute hepatitis of unknown etiology in a large cohort of children
title_fullStr Severe acute hepatitis of unknown etiology in a large cohort of children
title_full_unstemmed Severe acute hepatitis of unknown etiology in a large cohort of children
title_short Severe acute hepatitis of unknown etiology in a large cohort of children
title_sort severe acute hepatitis of unknown etiology in a large cohort of children
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531196/
https://www.ncbi.nlm.nih.gov/pubmed/37756118
http://dx.doi.org/10.1097/HC9.0000000000000272
work_keys_str_mv AT mehtasagar severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT johntomisin severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT feldjordanj severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT shahhemant severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT mullaithilaganisa severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT campigottoaaron severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT leungkaren severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT kamathbinitam severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT lingsimonc severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT sciencemichelle severeacutehepatitisofunknownetiologyinalargecohortofchildren
AT ngvickyl severeacutehepatitisofunknownetiologyinalargecohortofchildren